US2005074410A1PendingUtilityA1

Methods for diagnosis of allergic bronchopulmonary aspergillosis

Priority: Dec 20, 1996Filed: Jul 2, 2003Published: Apr 7, 2005
Est. expiryDec 20, 2016(expired)· nominal 20-yr term from priority
G01N 33/6854
34
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method for the diagnosis of ABPA in a human individual, comprising determining if the individual carries antibodies reactive with one or more ABPA-related recombinant allergens.

Claims

exact text as granted — not AI-modified
1 - 13 . (canceled)  
     
     
         14 . A method for the diagnosis of ABPA in a human individual, comprising determining if the individual carries antibodies reactive with one or more ABPA-related recombinant allergens which discriminate with 100% specificity between ABPA and allergic sensitization to  A. fumigatus.    
     
     
         15 . The method according to  claim 14 , wherein the allergen is derived from  A. fumigatus.    
     
     
         16 . The method according to  claim 15 , wherein the allergen corresponds to a non-secreted protein from  A. fumigatus.    
     
     
         17 . The method according to  claim 14 , wherein an in vitro immunoassay is carried out on a fluid sample from the individual for the determination of the level of antibodies directed towards said recombinate allergens.  
     
     
         18 . The method according to  claim 17 , wherein antibodies of the IgE class or IgE class, or subclasses thereof, are determined.  
     
     
         19 . The method according to  claim 17 , wherein antibodies of the IgE class are determined.  
     
     
         20 . The method according to  claim 14 , wherein an in vivo test is carried out in the individual.  
     
     
         21 . The method according to  claim 20 , wherein the test is a skin test involving placing said one or more ABPA-related recombinant allergens in the skin of the patient.  
     
     
         22 . The method according to  claim 20 , wherein antibodies of the IgE class or IgE class, or subclasses thereof, are determined.  
     
     
         23 . The method according to  claim 20 , wherein antibodies of the IgE class are determined.

Join the waitlist — get patent alerts

Track US2005074410A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.